Jörg Wissel mostly deals with Spasticity, Physical therapy, Anesthesia, Muscle tone and Randomized controlled trial. As part of his studies on Spasticity, he often connects relevant areas like Botulinum toxin type. The Physical therapy study combines topics in areas such as Dystonia, Botulinum toxin, Quality of life and Physical medicine and rehabilitation.
The concepts of his Physical medicine and rehabilitation study are interwoven with issues in Encephalopathy and Parkinsonian gait. The Epinephrine, Saline and Cerebral edema research Jörg Wissel does as part of his general Anesthesia study is frequently linked to other disciplines of science, such as Return of spontaneous circulation, therefore creating a link between diverse domains of science. Jörg Wissel has included themes like Stroke, Modified Ashworth scale and Paresis in his Muscle tone study.
His main research concerns Spasticity, Physical medicine and rehabilitation, Physical therapy, Anesthesia and Botulinum toxin. His study in Spasticity is interdisciplinary in nature, drawing from both Stroke, Muscle tone, Botulinum toxin type and Upper limb. In the field of Physical medicine and rehabilitation, his study on Lower limb spasticity and Upper limb spasticity overlaps with subjects such as Goal setting and Tower.
His research investigates the connection with Physical therapy and areas like Randomized controlled trial which intersect with concerns in Effective dose. Jörg Wissel focuses mostly in the field of Anesthesia, narrowing it down to topics relating to Neurological disorder and, in certain cases, Electromyography. His studies deal with areas such as Dystonia and Spastic as well as Botulinum toxin.
His primary scientific interests are in Spasticity, Physical medicine and rehabilitation, Stroke, Lower limb spasticity and Physical therapy. In his papers, Jörg Wissel integrates diverse fields, such as Spasticity and In patient. His work in the fields of Physical medicine and rehabilitation, such as Post stroke spasticity, intersects with other areas such as Goal setting.
His Stroke study combines topics in areas such as Magnetic resonance imaging and Emergency medicine. His study in Physical therapy is interdisciplinary in nature, drawing from both Quality of life, Randomized controlled trial and Statistical significance. Jörg Wissel works mostly in the field of Anesthesia, limiting it down to topics relating to Dose titration and, in certain cases, Elbow, as a part of the same area of interest.
His primary scientific interests are in Spasticity, Physical medicine and rehabilitation, Stroke, Physical therapy and Pandemic. He integrates many fields, such as Spasticity and European union, in his works. His work deals with themes such as Rehabilitation, Disease management and Cervical dystonia, Dystonia, which intersect with Physical medicine and rehabilitation.
In general Rehabilitation, his work in Goal Attainment Scaling is often linked to Acute care linking many areas of study. His biological study spans a wide range of topics, including Longitudinal study, Observational study, Treatment and control groups and Clinical endpoint. His Physical therapy research focuses on Lower limb spasticity in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
H.Kerr Graham;K.Roger Aoki;Ilona Autti-Rämö;Roslyn N Boyd.
Gait & Posture (2000)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke
A. M. O. Bakheit;A. F. Thilmann;A. B. Ward;W. Poewe.
European Consensus Table On the Use of Botulinum Toxin Type a in Adult Spasticity
Jörg Wissel;Anthony B. Ward;Per Erztgaard;Djamel Bensmail.
Journal of Rehabilitation Medicine (2009)
Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study
N Hyman;M Barnes;B Bhakta;A Cozens.
Journal of Neurology, Neurosurgery, and Psychiatry (2000)
Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy
G. Ebersbach;M. Sojer;F. Valldeoriola;J. Wissel.
Early development of spasticity following stroke: a prospective, observational trial.
Jörg Wissel;Ludwig D. Schelosky;Jeffrey Scott;Walter Christe.
Journal of Neurology (2010)
Toward an epidemiology of poststroke spasticity.
Jörg Wissel;Aubrey Manack;Michael Brainin.
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport
W Poewe;G Deuschl;A Nebe;E Feifel.
Journal of Neurology, Neurosurgery, and Psychiatry (1998)
Comparing exercise in Parkinson's disease—the Berlin BIG Study†
Georg Ebersbach;Almut Ebersbach;Daniela Edler;Olaf Kaufhold.
Movement Disorders (2010)
Management of spasticity associated pain with botulinum toxin A.
Jörg Wissel;Jörg Müller;Jürgen Dressnandt;Florian Heinen.
Journal of Pain and Symptom Management (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: